New developments in the management of head and neck cancer–impact of pembrolizumab
K Saleh, R Eid, FGH Haddad… - … and clinical risk …, 2018 - Taylor & Francis
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
[HTML][HTML] New developments in the management of head and neck cancer–impact of pembrolizumab
K Saleh, R Eid, FGH Haddad… - … and Clinical Risk …, 2018 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
New developments in the management of head and neck cancer-impact of pembrolizumab.
K Saleh, R Eid, FG Haddad… - … and Clinical Risk …, 2018 - europepmc.org
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
[PDF][PDF] New developments in the management of head and neck cancer–impact of pembrolizumab
K Saleh - Therapeutics and Clinical Risk Management, 2018 - pdfs.semanticscholar.org
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
[PDF][PDF] New developments in the management of head and neck cancer–impact of pembrolizumab
K Saleh - Therapeutics and Clinical Risk Management, 2018 - scienceopen.com
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
New developments in the management of head and neck cancer-impact of pembrolizumab.
K Saleh, R Eid, FGH Haddad… - … & Clinical Risk …, 2018 - search.ebscohost.com
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
New developments in the management of head and neck cancer–impact of pembrolizumab
K Saleh, R Eid, FGH Haddad… - … and Clinical Risk …, 2018 - search.proquest.com
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
New developments in the management of head and neck cancer-impact of pembrolizumab
K Saleh, R Eid, FG Haddad… - … and clinical risk …, 2018 - pubmed.ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
New developments in the management of head and neck cancer--impact of pembrolizumab
K Saleh, R Eid, FGH Haddad… - … and Clinical Risk …, 2018 - go.gale.com
Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco …
[引用][C] New developments in the management of head and neck cancer–impact of pembrolizumab
K Saleh, R Eid, FGH Haddad, N Khalife-Saleh… - … and Clinical Risk …, 2018 - cir.nii.ac.jp
New developments in the management of head and neck cancer – impact of
pembrolizumab | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
pembrolizumab | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …